Jim Simons Ironwood Pharmaceuticals Inc Transaction History

Renaissance Technologies LLC

$63.1 Billion
Q3 2024

A detailed history of Jim Simons (Renaissance Technologies LLC) transactions in Ironwood Pharmaceuticals Inc stock. As of the latest transaction made, Renaissance Technologies LLC holds 8,597,198 shares of IRWD stock, worth $29.6 Million. This represents 0.06% of its overall portfolio holdings.

Number of Shares

8,597,198

Previous 8,571,898 0.3%

Holding current value

$29.6 Million

Previous $55.9 Million 36.78%

% of portfolio

0.06%

Previous 0.1%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$3.93 - $7.04 $99,429 - $178,112	25,300 Added 0.3%	8,597,198 $35.3 Million
Q2 2024 Aug 09, 2024	BUY	$5.58 - $8.61 $8.21 Million - $12.7 Million	1,472,097 Added 20.73%	8,571,898 $55.9 Million
Q1 2024 May 13, 2024	BUY	$8.32 - $15.45 $4.19 Million - $7.79 Million	503,903 Added 7.64%	7,099,801 $61.8 Million
Q4 2023 Feb 13, 2024	BUY	$8.79 - $11.51 $7 Million - $9.16 Million	796,000 Added 13.72%	6,595,898 $75.5 Million
Q3 2023 Nov 14, 2023	BUY	$8.25 - $11.35 $3.96 Million - $5.45 Million	480,445 Added 9.03%	5,799,898 $55.9 Million
Q2 2023 Aug 11, 2023	BUY	$10.1 - $11.6 $6.89 Million - $7.91 Million	681,700 Added 14.7%	5,319,453 $56.6 Million
Q1 2023 May 12, 2023	BUY	$10.37 - $12.56 $2.73 Million - $3.31 Million	263,600 Added 6.03%	4,637,753 $48.8 Million
Q4 2022 Feb 13, 2023	SELL	$9.9 - $12.43 $9.89 Million - $12.4 Million	-999,000 Reduced 18.59%	4,374,153 $54.2 Million
Q3 2022 Nov 14, 2022	SELL	$10.14 - $12.38 $427,908 - $522,436	-42,200 Reduced 0.78%	5,373,153 $55.7 Million
Q2 2022 Aug 12, 2022	BUY	$11.05 - $12.72 $25.3 Million - $29.2 Million	2,292,300 Added 73.4%	5,415,353 $62.4 Million
Q1 2022 May 13, 2022	BUY	$10.61 - $12.88 $4.71 Million - $5.72 Million	443,800 Added 16.56%	3,123,053 $39.3 Million
Q4 2021 Feb 11, 2022	BUY	$10.86 - $13.95 $5.1 Million - $6.55 Million	469,700 Added 21.26%	2,679,253 $31.2 Million
Q3 2021 Nov 12, 2021	SELL	$11.92 - $13.92 $14.6 Million - $17.1 Million	-1,228,500 Reduced 35.73%	2,209,553 $28.9 Million
Q2 2021 Aug 13, 2021	BUY	$10.16 - $13.11 $3.02 Million - $3.9 Million	297,300 Added 9.47%	3,438,053 $44.2 Million
Q1 2021 May 13, 2021	BUY	$9.04 - $11.86 $10.3 Million - $13.5 Million	1,135,000 Added 56.59%	3,140,753 $35.1 Million
Q4 2020 Feb 10, 2021	BUY	$9.05 - $12.2 $9.85 Million - $13.3 Million	1,088,000 Added 118.55%	2,005,753 $22.8 Million
Q3 2020 Nov 13, 2020	SELL	$8.99 - $10.74 $3.56 Million - $4.25 Million	-396,100 Reduced 30.15%	917,753 $8.26 Million
Q2 2020 Aug 13, 2020	SELL	$9.14 - $11.97 $1.69 Million - $2.21 Million	-184,600 Reduced 12.32%	1,313,853 $13.6 Million
Q1 2020 May 14, 2020	BUY	$8.58 - $14.01 $6.39 Million - $10.4 Million	744,763 Added 98.82%	1,498,453 $15.1 Million
Q4 2019 Feb 13, 2020	BUY	$8.22 - $14.0 $5.49 Million - $9.35 Million	667,637 Added 775.84%	753,690 $10 Million
Q3 2019 Nov 13, 2019	BUY	$8.59 - $10.96 $739,195 - $943,140	86,053 New	86,053 $739,000
Q2 2019 Aug 12, 2019	SELL	$9.8 - $12.89 $3.5 Million - $4.61 Million	-357,453 Closed	0 $0
Q1 2019 May 14, 2019	BUY	$8.27 - $12.73 $2.96 Million - $4.55 Million	357,453 New	357,453 $4.84 Million

Others Institutions Holding IRWD

# of Institutions

238

Shares Held

162M

Call Options Held

11.2M

Put Options Held

9.1K

View Full List

About IRONWOOD PHARMACEUTICALS INC

Ticker IRWD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 153,231,008
Market Cap $527M
Description
Ironwood Pharmaceuticals, Inc., a healthcare company, focuses on the development and commercialization of gastrointestinal (GI) products. It markets linaclotide, a guanylate cyclase type-C agonist for the treatment of adults suffering from irritable bowel syndrome with constipation (IBS-C) or chronic idiopathic constipation (CIC) under the LINZE...

More about IRWD

Track Jim Simons's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Renaissance Technologies LLC, based on Form 13F filings with the SEC.

News

Stay updated on Renaissance Technologies LLC and Jim Simons with notifications on news.

Account